U.S. drug regulators are set to clear a third dose of Covid vaccines for people with weak immune systems as a new study showed the benefits of an extra shot in transplant patients.
In The News is a roundup of stories from The Canadian Press designed to kickstart your day. Here is what's on the radar of our editors for the morning of Aug. 12 .
(Bloomberg) A third dose of Moderna Inc.’s vaccine significantly raised antibody levels against the coronavirus in transplant patients, according a comparison of an extra shot to a placebo in people with weak immune systems.
The results could be influential.
The Food and Drug Administration is set to amend clearances as soon as Thursday for vaccines from both Moderna and Pfizer to allow extra doses for people with compromised immune systems.